| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001081346A3 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/21/2002 | WO2001078702A3 Methods and compositions for modulating alpha adrenergic receptor activity |
| 03/21/2002 | WO2001078529A3 Compositions and methods for improving vascular health |
| 03/21/2002 | WO2001076631A3 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 03/21/2002 | WO2001074902A3 Adenine binding g protein coupled receptors |
| 03/21/2002 | WO2001068568A3 Il-8 receptor antagonists |
| 03/21/2002 | WO2001064165A3 Il-8 receptor antagonists |
| 03/21/2002 | WO2001062905A3 Integrin antagonists |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001055106A3 Novel melanocortin receptor agonists and antagonists |
| 03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
| 03/21/2002 | WO2001042205A3 Treatment of inflammatory bowel disease with vitamin d compounds |
| 03/21/2002 | WO2001035943A3 Dextrose and insulin fluid formulation for intravenous infusion |
| 03/21/2002 | WO2001030375A3 Use of gdnf for treating corneal defects |
| 03/21/2002 | WO2001014372A3 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 03/21/2002 | US20020035737 Cloning pigs using donor nuclei from differentiated cells |
| 03/21/2002 | US20020035262 7-hetero-bicyclo[2.2.1]-heptanes |
| 03/21/2002 | US20020035151 Calcium formate for use as a dietary supplement |
| 03/21/2002 | US20020035147 Nervous system, psychological disorders |
| 03/21/2002 | US20020035140 1-(pyrrlolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/21/2002 | US20020035139 COX-2 inhibitors and the prevention of the side effects of radiation therapy |
| 03/21/2002 | US20020035122 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 03/21/2002 | US20020035110 Treatment or prevention of disorders of the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, and sleep apnea |
| 03/21/2002 | US20020035108 Method for treating allergies |
| 03/21/2002 | US20020035104 Integrin receptor inhibitors |
| 03/21/2002 | US20020035102 Azetidine derivatives, their preparation and medicaments containing them |
| 03/21/2002 | US20020035096 Formulations for treating or preventing mucositis |
| 03/21/2002 | US20020035094 Substituted pyridine compounds and methods of use |
| 03/21/2002 | US20020035093 Methods for the administration of amifostine and related compounds |
| 03/21/2002 | US20020035092 Propanoic acid derivatives |
| 03/21/2002 | US20020035089 Orlistat compositions |
| 03/21/2002 | US20020035081 Nucleic acid encoding a polypeptide of the virus' core protein having altered carboxyterminus, for reducing replication of a wild type hepadnavirus, by a dominant negative mechanism |
| 03/21/2002 | US20020035077 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 03/21/2002 | US20020034764 Diarylsulfonylurea binding proteins |
| 03/21/2002 | US20020034734 Vaccine composition for preventing or treating hepatitis C |
| 03/21/2002 | US20020034541 Oral solid pharmaceutical formulations with pH-dependent multiphasic release |
| 03/21/2002 | US20020034393 Vector |
| 03/21/2002 | DE10044325A1 Neue MMP-2-Derivate als Inhibitoren des Integrins avbeta3 New MMP-2 derivatives as inhibitors of the integrin avbeta3 |
| 03/21/2002 | CA2432780A1 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin f25g(a) antagonists |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422376A1 Isoxazoles and their use as inhibitors of erk |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422233A1 Interphenylene 7-oxabicyclic[2.2.1]heptane oxazoles as prostaglandin f2aantagonists |
| 03/21/2002 | CA2422095A1 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | CA2422076A1 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 03/21/2002 | CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 03/21/2002 | CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | CA2421279A1 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2420450A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188747A1 Phenoxypropylamine compounds |
| 03/20/2002 | EP1188445A1 Drug composition containing lecithin-modified superoxide dismutase |
| 03/20/2002 | EP1188442A2 Cinnamomi and poria composition, method to prepare the same and uses thereof |
| 03/20/2002 | EP1188438A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187838A1 Thiazolopyrimidines useful as tnf-alpha inhibitors |
| 03/20/2002 | EP1187836A1 Substituted imidazothiazoles as antidepressant agents |
| 03/20/2002 | EP1187834A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
| 03/20/2002 | EP1187831A1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 03/20/2002 | EP1187829A1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP1187815A1 4-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187814A2 5-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/20/2002 | EP1187613A1 Amide substituted imidazoquinolines |
| 03/20/2002 | EP1187605A1 Non-malignant disease treatment with ras antagonists |
| 03/20/2002 | EP1187591A2 Ibd-associated microbial antigens and methods of using same |
| 03/20/2002 | EP1011674B1 Transdermal therapeutic system containing the active substance scopolamine base |
| 03/20/2002 | EP0642351B1 New pharmaceutical uses of krill enzymes |
| 03/20/2002 | CN1341103A Pyridazin-3-one derivatives and medicines containing the same |
| 03/20/2002 | CN1341099A 2-aminopyridines containing fused ring substituents |
| 03/20/2002 | CN1341026A Small peptides and methods for treatment of asthma and inflammation |
| 03/20/2002 | CN1341022A Pharmaceutical composition containing porton pump inhibitors |
| 03/20/2002 | CN1341018A Gabapentin derivative for preventing and treating visceral pain |
| 03/20/2002 | CN1341016A Effervescent laxatives |
| 03/20/2002 | CN1340356A Chinese medicine for treating enterogastric disease |
| 03/20/2002 | CN1340353A Orally-applied medicine for treating hepatism and its preparing process |
| 03/20/2002 | CN1340352A Quick-acting powdered medicine for treating stomatopathy |
| 03/20/2002 | CN1340348A Instant wolfberry fruit-jujube kernel tea and its preparing process |
| 03/20/2002 | CN1340346A Medical wine for replenishing vital essence and invigorating vital function and its preparing process |
| 03/20/2002 | CN1081067C Chinese medicine prescription for curing hepatitis, cholangitis, pancreatitis and cirrhosis |
| 03/20/2002 | CN1081064C Medicine for treating diarrhea |
| 03/20/2002 | CN1081059C Medicinal capsule for treating stomach-ache |
| 03/20/2002 | CN1081057C Chinese medicine composition for treating oral disease and preparing method thereof |
| 03/20/2002 | CN1081038C Beta-glucan products and extraction process from cereals thereof |
| 03/20/2002 | CN1081021C Medicine deltoid belt for hernia |
| 03/19/2002 | US6359181 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 03/19/2002 | US6358987 For therapy and prophylaxis of rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, gingivitis, corneal epidermal or gastric ulceration, and tumour metastasis, invasion and growth |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358956 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358939 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 03/19/2002 | US6358930 Treatment of C. difficile toxin B associated conditions |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |